Works matching Dana-Farber Cancer Institute

Results: 5000
    1
    2
    3
    4

    Excellent therapeutic efficacy and minimal late neurotoxicity in children treated with 18 grays of cranial radiation therapy for high-risk acute lymphoblastic leukemia: a 7-year follow-up study of the Dana-Farber Cancer Institute Consortium Protocol 87-01.

    Published in:
    2001
    By:
    • Waber, Deborah P.;
    • Shapiro, Brenda L.;
    • Carpentieri, Sarah C.;
    • Gelber, Richard D.;
    • Zou, Guangyong;
    • Dufresne, Annie;
    • Romero, Ivonne;
    • Tarbell, Nancy J.;
    • Silverman, Lewis B.;
    • Sallan, Stephen E.;
    • Waber, D P;
    • Shapiro, B L;
    • Carpentieri, S C;
    • Gelber, R D;
    • Zou, G;
    • Dufresne, A;
    • Romero, I;
    • Tarbell, N J;
    • Silverman, L B;
    • Sallan, S E
    Publication type:
    journal article
    5
    6
    7

    Oral Mercaptopurine Adherence in Pediatric Acute Lymphoblastic Leukemia: A Survey Study From the Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium.

    Published in:
    Journal of Pediatric Hematology/Oncology Nursing, 2023, v. 40, n. 1, p. 17, doi. 10.1177/27527530221122685
    By:
    • Kahn, Justine M.;
    • Stevenson, Kristen;
    • Beauchemin, Melissa;
    • Koch, Victoria B.;
    • Cole, Peter D.;
    • Welch, Jennifer J. G.;
    • Gage-Bouchard, Elizabeth;
    • Karsenty, Cecile;
    • Silverman, Lewis B.;
    • Kelly, Kara M.;
    • Bona, Kira
    Publication type:
    Article
    8
    9

    Survival of Mexican Children with Acute Lymphoblastic Leukaemia under Treatment with the Protocol from the Dana-Farber Cancer Institute 00-01.

    Published in:
    BioMed Research International, 2015, v. 2015, p. 1, doi. 10.1155/2015/576950
    By:
    • Jiménez-Hernández, Elva;
    • Jaimes-Reyes, Ethel Zulie;
    • Arellano-Galindo, José;
    • García-Jiménez, Xochiketzalli;
    • Tiznado-García, Héctor Manuel;
    • Dueñas-González, María Teresa;
    • Martínez Villegas, Octavio;
    • Sánchez-Jara, Berenice;
    • Bekker-Méndez, Vilma Carolina;
    • Ortíz-Torres, María Guadalupe;
    • Ortíz-Fernández, Antonio;
    • Marín-Palomares, Teresa;
    • Mejía-Aranguré, Juan Manuel
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16

    Clinical features and treatment outcomes for primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer Institute and updated literature review.

    Published in:
    Leukemia & Lymphoma, 2022, v. 63, n. 12, p. 2832, doi. 10.1080/10428194.2022.2098287
    By:
    • Plumptre, Isabella R.;
    • Said, Jordan T.;
    • Sun, Tiffany;
    • Larocca, Cecilia;
    • Virgen, Cesar A.;
    • Kupper, Thomas S.;
    • Fisher, David C.;
    • Devlin, Philip M.;
    • Elco, Christopher P.;
    • Song, Johanna Sheu;
    • LeBoeuf, Nicole R.
    Publication type:
    Article
    17

    Cancer survivorship programs at the Dana-Farber Cancer Institute.

    Published in:
    Journal of Cancer Survivorship, 2024, v. 18, n. 1, p. 34, doi. 10.1007/s11764-023-01525-8
    By:
    • Partridge, Ann H.;
    • Morgans, Alicia;
    • Knelson, Lauren P.;
    • Recklitis, Christopher;
    • Nekhlyudov, Larissa;
    • Chi, Susan N.;
    • Kenney, Lisa B.;
    • Diller, Lisa;
    • Vrooman, Lynda M.
    Publication type:
    Article
    18
    19
    20

    XRCC1 and glutathione‐S‐transferase gene polymorphisms and susceptibility to radiotherapy‐related malignancies in survivors of Hodgkin disease: A report from the Childhood Cancer Survivor StudyThe following institutions and investigators participated in the Childhood Cancer Survivor Study (*institutional principal investigator; †former institutional principal investigator; ‡member of the Childhood Cancer Survivor Study Steering Committee): University of California–San Francisco, San Francisco, CA (Arthur Ablin, M.D.*); University of Alabama–Birmingham, Birmingham, AL (Roger Berkow, M.D.*); International Epidemiology Institute, Rockville, MD (John Boice, Sc.D.‡); University of Washington, Seattle, WA (Norman Breslow, Ph.D.‡); University of Texas–Southwestern Medical Center, Dallas, TX (George R. Buchanan, M.D.* and Kevin Oeffinger, M.D.‡); Dana‐Farber Cancer Institute, Boston, MA (Lisa Diller, M.D.,* Holcombe Grier, M.D.† and Frederick Li, M.D.‡); Texas Children's Cancer Center, Housto

    Published in:
    Cancer (0008543X), 2004, v. 101, n. 6, p. 1463, doi. 10.1002/cncr.20520
    By:
    • Ann C. Mertens;
    • Pauline A. Mitby;
    • Gretchen Radloff;
    • Irene M. Jones;
    • John Perentesis;
    • William R. Kiffmeyer;
    • Joseph P. Neglia;
    • Anna Meadows;
    • John D. Potter;
    • Debra Friedman;
    • Yutaka Yasui;
    • Leslie L. Robison;
    • Stella M. Davies
    Publication type:
    Article
    21

    A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignancies (Performed on behalf of the Darbepoetin Alfa 20010102 Study Group. The authors thank the study coordinators and patients at each of the participating centers. Janis Schaap, M.A., assisted in the writing of the article.) Additional members of the Darbepoetin Alfa 20010102 Study Group include the following: Luigi F. Bertoli, M.D. (Clinical Research Consultants, Inc., Hoover, Alabama); John T. Cole, M.D. (Ochsner Clinic Foundation, New Orleans, Louisiana); George Demetri, M.D. (Dana-Farber Cancer Institute, Boston, Massachusetts); Emmanuel Dessypris, M.D. (Hunter Holmes McGuire Department of Veterans Affairs Medical Center, Richmond, Virginia); Tracy Dobbs, M.D. (Baptist Hospital of East Tennessee, Knoxville, Tennessee); Peter Ei)

    Published in:
    Cancer (0008543X), 2004, v. 100, n. 4, p. 859, doi. 10.1002/cncr.11954
    By:
    • Paul J. Hesketh;
    • Francis Arena;
    • Dhimant Patel;
    • Matt Austin;
    • Paul D'Avirro;
    • Gregory Rossi;
    • Alan Colowick;
    • Lee Schwartzberg
    Publication type:
    Article
    22
    23
    24

    Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana‐Farber Cancer Institute ALL Consortium trial 05‐001.

    Published in:
    Pediatric Blood & Cancer, 2022, v. 69, n. 8, p. 1, doi. 10.1002/pbc.29581
    By:
    • Athale, Uma H.;
    • Flamand, Yael;
    • Blonquist, Traci;
    • Stevenson, Kristen E.;
    • Spira, Menachem;
    • Asselin, Barbara L.;
    • Clavell, Luis A.;
    • Cole, Peter D.;
    • Kelly, Kara M.;
    • Laverdiere, Caroline;
    • Leclerc, Jean‐Marie;
    • Michon, Bruno;
    • Schorin, Marshall A.;
    • Welch, Jennifer J.G.;
    • Harris, Marian H.;
    • Neuberg, Donna S.;
    • Sallan, Stephen E.;
    • Silverman, Lewis B.
    Publication type:
    Article
    25
    26
    27

    Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.

    Published in:
    2013
    By:
    • Luke, Jason J;
    • Callahan, Margaret K;
    • Postow, Michael A;
    • Romano, Emanuela;
    • Ramaiya, Nikhil;
    • Bluth, Mark;
    • Giobbie-Hurder, Anita;
    • Lawrence, Donald P;
    • Ibrahim, Nageatte;
    • Ott, Patrick A;
    • Flaherty, Keith T;
    • Sullivan, Ryan J;
    • Harding, James J;
    • D'Angelo, Sandra;
    • Dickson, Mark;
    • Schwartz, Gary K;
    • Chapman, Paul B;
    • Wolchok, Jedd D;
    • Hodi, F Stephen;
    • Carvajal, Richard D
    Publication type:
    journal article
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Outcome of children and adolescents with Down syndrome treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium protocols 00-001 and 05-001.

    Published in:
    2018
    By:
    • Athale, Uma H.;
    • Puligandla, Maneka;
    • Stevenson, Kristen E.;
    • Asselin, Barbara;
    • Clavell, Luis A.;
    • Cole, Peter D.;
    • Kelly, Kara M.;
    • Laverdiere, Caroline;
    • Leclerc, Jean‐Marie;
    • Michon, Bruno;
    • Schorin, Marshall A.;
    • Sulis, Maria Luisa;
    • Welch, Jennifer J. G.;
    • Harris, Marian H.;
    • Neuberg, Donna S.;
    • Sallan, Stephen E.;
    • Silverman, Lewis B.;
    • Leclerc, Jean-Marie
    Publication type:
    journal article
    37

    An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana‐Farber Cancer Institute ALL Consortium protocol 05‐001.

    Published in:
    Pediatric Blood & Cancer, 2018, v. 65, n. 3, p. 1, doi. 10.1002/pbc.26871
    By:
    • Kahn, Justine M.;
    • Cole, Peter D.;
    • Blonquist, Traci M.;
    • Stevenson, Kristen;
    • Jin, Zhezhen;
    • Barrera, Sergio;
    • Davila, Randy;
    • Roberts, Emily;
    • Neuberg, Donna S.;
    • Athale, Uma H.;
    • Clavell, Luis A.;
    • Laverdiere, Caroline;
    • Leclerc, Jean‐Marie;
    • Michon, Bruno;
    • Schorin, Marshall A.;
    • Welch, Jennifer J. G.;
    • Sallan, Stephen E.;
    • Silverman, Lewis B.;
    • Kelly, Kara M.
    Publication type:
    Article
    38

    An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001.

    Published in:
    2017
    By:
    • Kahn, Justine M;
    • Cole, Peter D;
    • Blonquist, Traci M;
    • Stevenson, Kristen;
    • Jin, Zhezhen;
    • Barrera, Sergio;
    • Davila, Randy;
    • Roberts, Emily;
    • Neuberg, Donna S;
    • Athale, Uma H;
    • Clavell, Luis A;
    • Laverdiere, Caroline;
    • Leclerc, Jean-Marie;
    • Michon, Bruno;
    • Schorin, Marshall A;
    • Welch, Jennifer J G;
    • Sallan, Stephen E;
    • Silverman, Lewis B;
    • Kelly, Kara M
    Publication type:
    journal article
    39
    40

    Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: Findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01.

    Published in:
    Pediatric Blood & Cancer, 2013, v. 60, n. 11, p. 1785, doi. 10.1002/pbc.24666
    By:
    • Waber, Deborah P.;
    • McCabe, Marie;
    • Sebree, Mikaela;
    • Forbes, Peter W.;
    • Adams, Heather;
    • Alyman, Cheryl;
    • Sands, Stephen A.;
    • Robaey, Philippe;
    • Romero, Ivonne;
    • Routhier, Marie‐Ève;
    • Girard, Jonathan M.;
    • Sallan, Stephen E.;
    • Silverman, Lewis B.
    Publication type:
    Article
    41

    Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: Report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01.

    Published in:
    Pediatric Blood & Cancer, 2011, v. 57, n. 3, p. 492, doi. 10.1002/pbc.23060
    By:
    • Mrakotsky, Christine M.;
    • Silverman, Lewis B.;
    • Dahlberg, Suzanne E.;
    • Alyman, M. Cheryl A.;
    • Sands, Stephen A.;
    • Queally, Jennifer T.;
    • Miller, Tamara P.;
    • Cranston, Amy;
    • Neuberg, Donna S.;
    • Sallan, Stephen E.;
    • Waber, Deborah P.
    Publication type:
    Article
    42
    43
    44

    Expression of IGF/insulin receptor in prostate cancer tissue and progression to lethal disease.

    Published in:
    Carcinogenesis, 2018, v. 39, n. 12, p. 1431, doi. 10.1093/carcin/bgy112
    By:
    • Ahearn, Thomas U;
    • Peisch, Sam;
    • Pettersson, Andreas;
    • Ebot, Ericka M;
    • Zhou, Cindy Ke;
    • Graff, Rebecca E;
    • Sinnott, Jennifer A;
    • Fazli, Ladan;
    • Judson, Gregory L;
    • Bismar, Tarek A;
    • Rider, Jennifer R;
    • Gerke, Travis;
    • Chan, June M;
    • Fiorentino, Michelangelo;
    • Flavin, Richard;
    • Sesso, Howard D;
    • Finn, Stephen;
    • Giovannucci, Edward L;
    • Gleave, Martin;
    • Loda, Massimo
    Publication type:
    Article
    45

    Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG-PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade.

    Published in:
    2019
    By:
    • Jacene, Heather A.;
    • Youn, Trisha;
    • DiPiro, Pamela J.;
    • Hu, Jiani;
    • Cheng, Su-Chun;
    • Franchetti, Yoko;
    • Shah, Hina;
    • Bellon, Jennifer R.;
    • Warren, Laura;
    • Schlosnagle, Emily;
    • Nakhlis, Faina;
    • Rosenbluth, Jennifer;
    • Yeh, Eren;
    • Overmoyer, Beth;
    • Dana-Farber Cancer Institute Inflammatory Breast Cancer Program
    Publication type:
    journal article
    46

    Resultados del tratamiento a largo plazo de 209 niños con leucemia linfoblástica aguda: experiencia de un grupo multicéntrico en Venezuela.

    Published in:
    Clinical & Translational Oncology, 2003, v. 5, n. 8, p. 450, doi. 10.1007/BF02710368
    By:
    • Perera, Alicia;
    • Navarro, Ciramar;
    • Landolfi, Clementina;
    • Cárdenas, Leonor;
    • Inaty, Joaquín;
    • Insausti, Carmen;
    • Guevara, José;
    • González, Sandra;
    • Costa, Marisol;
    • Carneiro, Maritza;
    • Ramírez, Pedro;
    • Mora, Arfilio;
    • Ramirez, Francisco;
    • Garcia, Raiza;
    • Benavides, Isidro;
    • Sevilla, Simón;
    • Campos, Jesús;
    • Quevedo, Maria;
    • Miliani, Efraín;
    • Castellanos, Hernán
    Publication type:
    Article
    47
    48
    49
    50